Scholarlink

<p>The 2024 European Society for Medical Oncology (ESMO) Congress showcased pivotal advances in the management of gynecologic cancers. This review highlights the most impactful research, emphasizing innovations in therapeutic strategies, biomarkers, and personalized care. Key studies addressed novel approaches in ovarian, endometrial, and cervical cancers, providing a&#xa0;framework for translating these findings into clinical practice.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Best of ESMO 2024: gynecologic cancers

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月12日

查看全文
  • Stephan Polterauer

摘要

The 2024 European Society for Medical Oncology (ESMO) Congress showcased pivotal advances in the management of gynecologic cancers. This review highlights the most impactful research, emphasizing innovations in therapeutic strategies, biomarkers, and personalized care. Key studies addressed novel approaches in ovarian, endometrial, and cervical cancers, providing a framework for translating these findings into clinical practice.